EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophylactic Inhalation of Bergamot Essential Oil Ameliorates Hormone‐Simulated Pseudopregnancy Withdrawal‐Induced Postpartum Depression by Modulating Hippocampal Synaptic Plasticity

Prophylaktische Inhalation von Bergamotte-Ätherischem Öl verbessert hormon-simulierte Pseudograviditäts-Entzug-induzierte postpartumähnliche Depression durch Modulation der synaptischen Plastizität im Hippocampus

Huan Xu, Shike Zhang iD, Hui He, Xue Zhao, Yupei Cheng iD, Yingdong Wang iD, Jinzhou Li, Yi Yu, Yuhong Bian, Yi Guo iD, Mingxing Zhang iD

Journal of Cellular and Molecular Medicine · 2026-10 · 30 (20)

DOI: 10.1111/jcmm.71395 ↗

Auf einen Blick

In einem Rattenmodell mit PPD-ähnlichen Symptomen verbesserte inhalatives Bergamotte-Ätherisches Öl das Verhalten und Marker der synaptischen Plastizität. Prophylaktische und therapeutische Gabe wirkten ähnlich.

Fragestellung

Verbessert prophylaktische oder therapeutische Inhalation von Bergamotte-Ätherischem Öl PPD-ähnliche Symptome im Rattenmodell und beeinflusst hippocampale Synapsen und Entzündungsmarker?

Methode

Rattenmodell mit hormon-simulierter Pseudogravidität und abruptem Entzug; Vergleich von Kontrolle, Sham, Modell, Fluoxetin, therapeutischem BEO und prophylaktischem BEO. Verhaltenstests, Histologie, Immunhistochemie, Western Blot, ELISA und Docking.

Ergebnisse

BEO erhöhte Saccharosepräferenz, Laufstrecke und Open-Arm-Zeit und steigerte Nissl-Körper sowie PSD-95/SYP. IGF-1 stieg, IL-1β sank, IL-10 stieg; keine relevanten Veränderungen in Thymus oder Milz.

Einschränkungen

Präklinische Tierstudie; Ergebnisse als vorläufig beschrieben.

Schlussfolgerung der Autor:innen

Die Autor:innen schließen, dass BEO-Inhalation PPD-ähnliche Phänotypen in diesem Rattenmodell abschwächen kann, möglicherweise über synaptische Plastizität und Neuroinflammation.

Kernaussagen

  • Saccharosepräferenz, Laufstrecke und Open-Arm-Zeit nahmen unter BEO zu.
  • Hippocampale Nissl-Körper sowie PSD-95/SYP stiegen unter BEO.
  • IGF-1 nahm zu, IL-1β ab und IL-10 zu.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 22.10.2026. Verfasst von Huan Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrated Traditional Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China. Hauptthemen laut MEDLINE: Neuronal Plasticity, Hippocampus, Plant Oils, Oils, Volatile. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, the Key Project of National Natural Science Foundation of China.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postpartum depression (PPD) affects approximately 17.2% of women giving birth globally, but current pharmacotherapies face significant limitations including invasive intravenous delivery (brexanolone) and high costs Bergamot essential oil (BEO) has demonstrated efficacy in aromatherapy for depression, yet its role in PPD remains unexplored. This study investigated whether prophylactic or therapeutic inhalation of nebulized BEO ameliorates PPD‐like phenotypes in a rat model of hormone‐simulated pseudopregnancy (HSP) with abrupt withdrawal, and explored potential mechanisms involving hippocampal synaptic plasticity and neuroinflammation. The main components of BEO were characterized using gas chromatography–mass spectrometry (GC–MS). A rat model of PPD was constructed using the HSP post‐withdrawal method, and animals were randomly divided into control group (Ctrl), sham surgery group (Sham), model group (PPD), fluoxetine group (Flu; 10 mg/kg, i.p., post‐modelling) as a positive control representing first‐line SSRI therapy (brexanolone, though FDA‐approved for PPD, requires costly intravenous administration and specialized medical supervision, and was therefore not used as a comparator), therapeutic BEO group (BEO; 2.5% v/v inhalation post‐modelling) and prophylactic BEO group (P‐BEO; 2.5% v/v inhalation during HSP modelling). The sucrose preference test (SPT), open field test (OFT) and elevated plus maze (EPM) were used to evaluate the depressive‐like behaviours, and HE staining was used to observe the effects of BEO on the thymus and spleen of immune organs. Nissl staining was utilized to quantify the Nissl bodies in the hippocampus (HIPP) of PPD model rats. Additionally, immunohistochemistry and Western blotting were conducted to detect alterations in postsynaptic density protein‐95 (PSD‐95) and synaptophysin (SYP) within the hippocampus of the rats. Enzyme‐linked immunosorbent assay (ELISA) was employed to further analyse the levels of insulin‐like growth factor‐1 (IGF‐1, a neurotrophic factor linked to synaptic plasticity), interleukin‐1β (IL‐1β, a pro‐inflammatory cytokine implicated in PPD pathogenesis) and interleukin‐10 (IL‐10, an anti‐inflammatory cytokine implicated in PPD pathogenesis) in serum, cerebrospinal fluid (CSF) and HIPP. Molecular docking was performed to predict interactions between BEO's core constituents (limonene, γ‐terpinene, α‐pinene, β‐pinene, α‐phellandrene) and target proteins (PSD‐95, SYP, IL‐1β, IGF‐1, IL‐10). Both therapeutic and prophylactic BEO inhalation significantly increased sucrose preference (from 78.78% ± 17.25% to 96.44% ± 2.60% [BEO] and 97.33% ± 0.87% [P‐BEO], p < 0.05), total distance travelled in the OFT (from 900.07 ± 523.07 to 1932.64 ± 665.88 cm [BEO] and 1671.51 ± 544.36 cm [P‐BEO]; p < 0.05) and open arm time in the EPM (from 16.34 ± 15.44 to 49.91 ± 24.99 s [BEO] and 50.81 ± 16.12 s [P‐BEO]; p < 0.05). Both BEO groups exhibited increased Nissl body counts in hippocampal CA1 (from 7.44 ± 1.59 to 18.44 ± 2.60 [BEO] and 19.56 ± 2.07 [P‐BEO]; p < 0.05), CA2, CA3 and DG subregions ( p < 0.05 vs. PPD), as well as increased PSD‐95/SYP protein abundance. Both BEO regimens increased IGF‐1 levels in serum and CSF ( p < 0.05 vs. PPD), with the P‐BEO group showing a significantly higher serum IGF‐1 levels compared to the Flu group ( p < 0.05). Additionally, both P‐BEO and BEO groups decreased IL‐1β levels in serum and HIPP, while increasing IL‐10 levels in the CSF ( p < 0.05 vs. PPD for all). Molecular docking revealed favourable binding affinities (binding energy < −5.0 kcal/mol) between BEO constituents and all five target proteins. No significant histopathological alterations were observed in thymus or spleen following BEO exposure. Collectively, these findings suggest that BEO inhalation may attenuate PPD‐like phenotypes in this rat model, potentially through modulation of hippocampal synaptic plasticity and neuroinflammation via regulation of IGF‐1, IL‐1β and IL‐10. While these results are preliminary, the non‐invasive delivery and observed dual‐phase efficacy suggest that BEO inhalation may represent a more accessible approach worthy of further investigation for PPD management, particularly in resource‐limited settings where current FDA‐approved treatments are unavailable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuronal PlasticityHippocampusPlant OilsOils, VolatileDepression, PostpartumAnimalsFemaleRatsAdministration, InhalationRats, Sprague-DawleyDisease Models, AnimalPregnancySynaptophysinDisks Large Homolog 4 Protein

Stichwörter der Autor:innen

aromatherapybergamot essential oilhippocampusneuroplasticitypostpartum depressionprophylactic administration

Substanzen

Plant OilsOils, Volatilebergamot oilSynaptophysinDisks Large Homolog 4 Protein

Autor:innen und Institutionen

  • School of Integrated Traditional Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
  • Research Center of Experimental Acupuncture, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
  • National Clinical Research Center for Chinese Medicine, Tianjin, P. R. China.
  • Department of Reproductive Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China.

ORCID-Profile: Shike Zhang, Yupei Cheng, Yingdong Wang, Yi Guo, Mingxing Zhang

Förderung

  • National Key Research and Development Program of China
  • the Key Project of National Natural Science Foundation of China

Zitieren

APA

Xu, H., Zhang, S., He, H., Zhao, X., Cheng, Y., Wang, Y., Li, J., Yu, Y., Bian, Y., Guo, Y., & Zhang, M. (2026). Prophylactic Inhalation of Bergamot Essential Oil Ameliorates Hormone‐Simulated Pseudopregnancy Withdrawal‐Induced Postpartum Depression by Modulating Hippocampal Synaptic Plasticity. Journal of Cellular and Molecular Medicine, 30(20). https://doi.org/10.1111/jcmm.71395

Vancouver

Xu H, Zhang S, He H, Zhao X, Cheng Y, Wang Y, et al. Prophylactic Inhalation of Bergamot Essential Oil Ameliorates Hormone‐Simulated Pseudopregnancy Withdrawal‐Induced Postpartum Depression by Modulating Hippocampal Synaptic Plasticity. Journal of Cellular and Molecular Medicine. 2026;30(20). doi:10.1111/jcmm.71395

BibTeX
@article{Xu2026,
  author = {Xu, Huan and Zhang, Shike and He, Hui and Zhao, Xue and Cheng, Yupei and Wang, Yingdong and Li, Jinzhou and Yu, Yi and Bian, Yuhong and Guo, Yi and Zhang, Mingxing},
  title = {Prophylactic Inhalation of Bergamot Essential Oil Ameliorates Hormone‐Simulated Pseudopregnancy Withdrawal‐Induced Postpartum Depression by Modulating Hippocampal Synaptic Plasticity},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {20},
  doi = {10.1111/jcmm.71395}
}
Kostenlos starten →